Marketresearchnews

Wednesday, 26 August 2020

Whole Exome Sequencing Market 2019 Analysis, Opportunities And Forecast To 2025

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Whole Exome Sequencing Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

As per Market Research Future (MRFR) analysis, the global whole exome sequencing market is estimated to reach USD 2,696.03 million with a CAGR of 19.80% from 2019 to 2025 (forecast period).

Whole exome sequencing is a broadly used next-generation sequencing (NGS) method to determine the nucleotide sequence primarily of protein-coding regions of individual-related sequences, reflecting approximately 1% of the complete DNA sequence. Human exome accounts for less than 2% of the genome but contains -85% of known disease-related variants. This is the primary explanation for the use of exome in the detection and determination of genetic variants that cause different diseases, such as Miller syndrome and Alzheimer's.

ALSO READ : https://www.marketwatch.com/press-release/covid-19-outbreak-impact-on-whole-exome-sequencing-market-2020-industry-analysis-global-size-share-top-company-profile-regional-outlook-2020-06-02?tesla=y

Whole Exome Sequencing Market Dynamics

Factors driving market growth include decreasing sequencing costs, the use of whole exome sequencing technology for a variety of applications, and strategic alliances between key players and research institutes.

Moreover, market players are operating in the global exome sequencing market emphasis on product launches, approvals, and collaborations to gain market dominance and keep their product updated and in demand. For example, in November 2019, NantHealth, Inc. (US), a next-generation, personalized healthcare company, received FDA approval from Omics CoreSM, the first whole exome sequencer used to examine both tumor and somatic genes to determine the overall tumor mutation burden (TMB) in cancer tissue.

However, the lack of qualified professionals and ethical and legal concerns related to whole exome sequencing are hindering the growth of the industry.

Whole Exome Sequencing Market Segmentation

The global whole exome sequencing market has been segmented based on the product, technology, application, and end-user.

Based on the product, the global market for whole exome sequencing has been segmented into kits, sequencer, and services. Kits are further divided into DNA Fragmentation, A-Tailing, End Repair, Size Selection Kits, Target Enrichment, and Library Preparation. Services are further sub-segmented into Data Analysis (Bioinformatics), Sequencing Services, and Others.

Based on technology, the global market for whole exome sequencing has been classified as Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, and others.

Based on application, the global market for whole exome sequencing has been segmented into diagnostics, drug discovery, development, agriculture, animal research, and others.

Based on end-user, the global market for whole exome sequencing has been segmented into research centers, government institutes, hospitals and diagnostics centers, pharmaceutical and biotechnology companies, and others.

Whole Exome Sequencing Market Regional Analysis

The global market for whole exome sequencing is segmented into the Americas, Europe, the Asia Pacific, and the Middle East & Africa.

The Americas were the biggest whole exome sequencing market in 2019. The expansion of the Americas market is due to the increasing prevalence of cancer and other chronic disorders and rising healthcare expenditure. In addition, favorable initiatives by the government and other organizations for the development and adoption of whole exome sequencing technologies are fueling the market growth for whole exome sequencing. For example, in 2018, the All Us Research Program, part of the National Institutes of Health, received more than USD 28.6 million in funding to establish three genome centers in the US.

Europe is the second-largest whole exome sequencing market in Western Europe, with the largest market share. The European market is projected to have a steady growth rate during the forecast period due to growing cancer cases and increasing genome sequencing programs. As per the International Agency for Cancer Research, there were nearly 4,229,662 cases of cancer in Europe in 2018. These huge cancer cases and increasing genome mapping programs are expected to have a significant impact on the growth of the whole exome sequencing market.

The Asia Pacific is projected to show the highest potential for market growth over the forecast period due to the rising patient pool and growing technological advancements. The rapid growth of the Asia Pacific region is due to an increase in per capita income and government initiatives to improve the quality of healthcare. China, India, and Australia have a profitable market for whole exome sequencing due to the growing elderly population.

In the Middle East & Africa, the whole exome sequencing market accounts for a substantial market share. Countries such as Kuwait, Saudi Arabia, and the UAE are expected to see steady growth due to a rise in cancer cases, increasing government efforts to enhance health care, and favorable reimbursement policies. Nevertheless, the rest of the Middle East and Africa may show inactive growth due to affordability and accessibility issues.

Whole Exome Sequencing Market Key Players

The prominent participants in the global whole exome sequencing market are Illumina Inc. (US), BGI (China), Eurofins Scientific (Belgium), Agilent Technologies, Inc. (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Ambry Genetics (US), GENEWIZ (US), Macrogen, Inc. (South Korea), Integragen SA (France), and others.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/whole-exome-sequencing-market-8763

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Handheld Surgical Devices Market Dynamics, Forecast, Analysis And Supply Demand 2020

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Handheld Surgical Devices Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Handheld Surgical Devices Market Analysis

The global handheld surgical devices market is expected to exhibit a strong CAGR of 6.8% over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global handheld surgical devices market is likely to grow at a steady pace over the forecast period, leading to a high overall valuation by the end of the forecast period. The report studies the market’s major drivers and restraints, as well as the leading players operating in the global market. The impact of the COVID-19 pandemic on the handheld surgical devices market is also assessed in the report.

ALSO READ : https://www.medgadget.com/2020/07/handheld-surgical-devices-market-growth-2020-covid-19-impact-analysis-size-estimation-industry-share-top-company-analysis-regional-revenue-cagr-value.html

Handheld surgical devices are various types of devices used by surgeons during surgery. They are specially designed so as to enable surgeons to perform surgeries with a high accuracy. The degree of precision available in surgeries matters, as this results in fewer accidents or mishaps. This has led to a growing demand for handheld surgical devices made to a high standard. The medical devices industry has come up with new and improved standards for handheld surgical devices in recent years in order to ensure high standards in handheld surgical devices. This is likely to be a major driver for the global handheld surgical devices market over the forecast period.

The increasing demand for surgical procedures, especially cardiovascular, neurological, and ophthalmic surgeries, is likely to be a major driver for the global handheld surgical devices market. The increasing prevalence of sedentary lifestyles has resulted in a growing demand for cardiovascular surgeries to prevent serious consequences such as heart attacks. The increasing air pollution and increasing use of blue screens such as desktops and laptops, in addition to mobiles, has resulted in a growing demand for cataract and other ophthalmic surgeries. This is likely to remain a major driver for the global handheld surgical devices market over the forecast period. On the other hand, the lack of skilled and trained physicians and the stringent government regulations are likely to be the major restraints on the global handheld surgical devices market over the forecast period.

Handheld Surgical Devices Market Competitive Leaderboard:

Leading players in the global handheld surgical devices market include CooperSurgical Inc., KLS Martin, Aspen Surgical, Stryker, Thompson Surgical, Becton Dickinson and Company, Elite Medical, Medicon AG, Millennium Surgical Corp., Johnson & Johnson, Smith & Nephew, Medtronic, Pelion Surgical, Zimmer Biomet Holdings, Integra LifeSciences Corporation, and B. Braun Melsungen AG.

Handheld Surgical Devices Market Segmentation:

The global handheld surgical devices market is segmented on the basis of application, product, end use, and region.

By application, the global handheld surgical devices market is segmented into neurology, urology, orthopedics, gynecology, cardiovascular, wound closure, and others. Neurology and cardiology segments are likely to hold dominant shares in the global handheld surgical devices market over the forecast period.

By product type, the global handheld surgical devices market is segmented into forceps and spatulas, retractors, dilators, graspers, auxiliary devices, cutter devices, and others including punches, curettes, blunt dissectors, and snares. The auxiliary devices segment is segmented into clamps, cannulas, and closure devices. The cutter devices segment is segmented into trocars, lancets, and scissors.

By end use, the global handheld surgical devices market is segmented into hospitals, clinics, ambulatory surgical centers, research and academic institutes, and others. Clinics and hospitals held a dominant share in the global handheld surgical devices market in 2017 due to the high volume of surgical procedures carried out in hospitals and clinics.

Handheld Surgical Devices Market Regional Analysis:

The Americas dominated the global handheld surgical devices market in 2017 and is likely to remain the leading regional market for handheld surgical devices over the forecast period. The strong presence of numerous leading players in the Americas region is the major driver for the regional market. The growing prevalence of chronic diseases in the region is also likely to be a major driver for the global handheld surgical devices market over the forecast period. Europe holds the second largest share in the global handheld surgical devices market, followed by Asia Pacific.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/handheld-surgical-devices-market-7210

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Liquid Biopsy Market, Segments, Growth And Value Chain Analysis 2020

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Liquid Biopsy Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Liquid Biopsy Market Analysis

The global liquid biopsy market value is likely to touch USD 17,372.28 million at a whopping 28.0% CAGR between 2014- 2022, according to the new report by Market Research Future (MRFR). Liquid biopsy, simply put, is a minimally invasive test used to assess the cancer genetic status resting on the analysis of the circulating biomarker, which is present in the blood’s plasma component. Some of its wide applications include reproductive health, cancer, and others.

Various factors are adding to the global liquid biopsy market growth. According to the new MRFR report, such factors include growing awareness regarding the diagnosis of different types of cancer, multiple benefits of liquid biopsy such as less labor required, low cost, identification of specific mutations, and quick analysis, and extensive R&D in the diagnosis and treatment of cancer. Besides, the rising prevalence of cancer and burgeoning demand for non-invasive testing are also adding market growth.

ALSO READ : https://www.medgadget.com/2020/07/liquid-biopsy-market-size-to-touch-usd-17372-28-million-at-28-0-cagr-by-2022.html

On the contrary, tumor heterogeneity being the biggest challenge in cancer research may limit the global liquid biopsy market growth over the forecast period. Besides, the production process in its entirety being adversely impacted due to the temporary shutdown of industries and complete lockdown following the COVID-19 pandemic that has limited the overall blood collection tubes for the global liquid biopsy market is also hindering the market growth.

Liquid Biopsy Market Segmentation

The MRFR report gives an inclusive segmental analysis of the global liquid biopsy market report based on end user, samples, application, and types.

By types, the global liquid biopsy market is segmented into extracellular vesicles (EVS), circulating tumor DNA (CTDNA), circulating tumor cells (CTCS), and others. Of these, the circulating tumor cells segment will lead the market over the forecast period.

By application, the global liquid biopsy market is segmented into reproductive health, cancer, and others.

By sample, the global liquid biopsy market is segmented into forensic, urine sample, blood sample, and others. Of these, the blood sample segment will dominate the market over the forecast period.

By end user, the liquid biopsy market is segmented into academic & research centers, hospitals and laboratories, and others. Of these, the hospitals and laboratories segment will have a major share in the market over the forecast period.

Liquid Biopsy Market Regional Analysis

Based on the region, the global liquid biopsy market report covers the growth opportunities and recent trends across North America, Europe, the Asia Pacific (APAC), & the Middle East and Africa (MEA). Of these, North America will spearhead the market over the forecast period. Improving healthcare infrastructure, increasing prevalence of cancer, and surging demand for non-invasive treatment is adding to the global liquid biopsy market growth in the region. The US has the maximum share in the region.

The global liquid biopsy market in the APAC region is predicted to grow at a fast pace over the forecast period. The government’s focus on healthcare facilities, growing cancer cases, increased urbanization, and rising income are adding to the liquid biopsy market growth in the region.

The global liquid biopsy market in Europe is predicted to hold the second-largest share over the forecast period. Rising geriatric population, growing prevalence of cancer, and a huge base of research & academic institutes & biopharmaceutical companies are adding to the liquid biopsy market growth in the region.

The global liquid biopsy market in the MEA is predicted to have sound growth over the forecast period.

Liquid Biopsy Market Key Players

Eminent players profiled in the global liquid biopsy market report include Exosome Diagnostics (Massachusetts), SAGA Diagnostics AB (Sweden), Inivata Ltd (UK), Circulogene Theranostics (Alabama), Biocept, Inc. KGaA (US), Admera Health (US), Agena Bioscience Inc. (California), RainDance Technologies, Inc. (US), Trovagene, Inc. (California),and Guardant Health, Inc. (US).

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Atherectomy Devices Research Report And Overview On Atherectomy Devices Market, 2020

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Atherectomy Devices Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Scenario

Atherectomy devices are built to either shave, cut, vaporize, laser or sand the plaques. The devices come with different indications. Different atherectomy devices have been invented for commercial use. The location of the plaque and type of blockage influence the choice of atherectomy device to be used. Some atherectomy devices are used only in the larger arteries on the upper portion of the knee, while other devices come with smaller catheters that are suitable for operating the arteries below the knee.

Atherectomy is a technique applied to eliminate atherosclerotic plaque from affected arteries. The plaques are in either peripheral or coronary arterial vasculature and may have distinct characteristics depending on the nature of the plaque. Atherectomy is used widely in cure of both peripheral and coronary arterial ailments. It is a minimally invasive endovascular surgery.

Also Read : https://www.medgadget.com/2020/07/covid-19-pandemic-impact-on-transthyretin-ttr-amyloidosis-market-2020-global-industry-size-share-business-opportunities-new-advancement-strategies-sales-revenue-regional-statistics.html

The worldwide Atherectomy devices industry is likely to develop remarkably over the forecast period. It is projected that the global atherectomy devices market will register a CAGR of 6.12% over the forecast period of 2018–2023. In 2017, the estimated market value was around 1.09 billion.

The growing rate of peripheral and coronary arterial diseases coupled with increasing demand for minimally invasive techniques is predicted to boost the growth of the atherectomy devices market. Minimally invasive surgical techniques deliver quicker recovery, quick procedural time, lesser risk of infections and complications. The worldwide atherectomy devices market is likely to witness noteable surge in demand due to exponential growth in the incidence of lifestyle-related ailments and elderly population.

Segmentation

The global atherectomy devices market is segmented on the basis of product type, application, and end user.

Based on application, the atherectomy devices market is segmented into cardiovascular, neurovascular, peripheral vascular, and others.

The atherectomy devices market, by product type is categorised into directional atherectomy systems, orbital atherectomy systems, photo-ablative (laser) atherectomy systems, rotational atherectomy systems, and others.

The directional atherectomy systems segment is expected to hold the largest share owing to the high treatment rate, whereas the photo-ablative (laser) atherectomy systems is expected to be the fastest growing segment owing to the growing preference by surgeons.

On the basis of end user, the market is segmented into hospitals, ambulatory surgery centers, and others.

On the basis of region, the global atherectomy devices market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. The atherectomy devices market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Asia-Pacific was projected to be the fastest growing region for the global atherectomy devices market. This owes to the technological advancements resulting in the development of cost-effective atherectomy devices leading to high acceptance rate for the devices in the Asia-Pacific region. The Middle East and Africa holds the least share in the global atherectomy devices market due to the presence of economically diverse countries, and less initiatives taken by the government.

It is projected that the Americas dominated the global atherectomy devices market owing to the growth of the market in the North American region. This is largely attributed to the factors such as increase in research funding, and growing awareness about the high-end atherectomy devices among medical professionals. Europe is expected to hold the second largest share in the atherectomy devices market owing to growing healthcare infrastructure. Additionally, various initiatives by public and private organizations is anticipated to boost the growth of the atherectomy devices market.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/atherectomy-devices-market-7322

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Worldwide Transthyretin (TTR) Amyloidosis Market 2019 Outlook, Top 10 Industry Players Comprehensive Analysis And Forecast To 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Transthyretin (TTR) Amyloidosis Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide DemandTransthyretin (TTR) Amyloidosis Market Analysis

Market Research Future (MRFR) report on the global transthyretin (TTR) amyloidosis market (2018-2023) analyzes COVID-19 on the main factors that drive market growth. The study addresses competitors in the market and global market trends, offering a detailed summary of both growth factors and constraints, which may have a direct or indirect effect on the outlook of the industry during the forecast period.

Transthyretin (TTR) amyloidosis is a medical disorder characterized by the build-up of irregular protein deposits called amyloid (amyloidosis) in the body’s organs and tissues. It primarily affects the peripheral neuropathic or autonomic neuropathic system and the cardiac system. The cardiac type of transthyretin (TTR) amyloidosis puts patients at risk of arrhythmia, cardiomegaly, and orthostatic hypertension.

Transthyretin (TTR) Amyloidosis Market Key Players

Some of the key players identified by MRFR in this market are Alnylam Pharmaceuticals, Pfizer, Merck, Arcturus Therapeutics, Ionis Pharmaceuticals Inc., Corino Therapeutics Inc, Proclara Bioscience.

Transthyretin (TTR) Amyloidosis Market Dynamics

The global ATTR market is expected to show robust growth during the forecast period due to the probability of an increase in the number of ATTR drug launches, an increase in the Afro-American population as they are genetically susceptible to amyloidosis, an increase in people’s health awareness and the average income of individuals.

Nevertheless, the growth of this market can be hampered by strict regulatory policies, the high cost of ATTR drugs, the inaccurate diagnosis of ATTR disorders, and clinical trials’ limitations. Lack of information on this condition and inadequacy of advanced diagnostic methods in middle-income countries are significant market barriers.

Transthyretin (TTR) Amyloidosis Market Segmentation

The global transthyretin (TTR) amyloidosis market has been segmented based on disease type, treatment, gender, and end-user.

Based on the type of disease, the global market for transthyretin (TTR) amyloidosis has been segmented into transthyretin (TTR) familial amyloid cardiomyopathy, transthyretin (TTR) familial amyloid polyneuropathy, and others.

Based on treatment, the global market for transthyretin (TTR) amyloidosis has been segmented into small molecules treatment, organ transplantation, RNAi therapy and others. The segment for small molecules treatment is further divided into tafamidis and diflunisal.

Based on gender, the global market for transthyretin (TTR) amyloidosis has been segmented into males and females.

Based on the end-user, the global market for transthyretin (TTR) amyloidosis has been segmented into hospitals and clinics, ambulatory surgical centers, and others.

Transthyretin (TTR) Amyloidosis Market Regional Analysis

By region, the global market for transthyretin (TTR) amyloidosis has been segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas leads the market for transthyretin amyloidosis (TTR) due to a growing prevalence of amyloidosis among adults and the elderly and a rising geriatric population, which is a significant cause for this disease. For example, according to a study released by ASCO Journal in 2016, approximately 4,000 people develop amyloidosis per year in the United States. As a result, this growing patient pool will fuel demand growth during the forecast period. In addition, factors such as increasing government initiatives and support for research, the advancement of advanced medical treatment options, and the growing usage of technologically advanced medical diagnostic devices are likely to propel the market. The presence of pharmaceutical giants such as Pfizer, Merck, etc. is also driving market growth in this region.

Europe is the second-largest market and has a fair share of the overall market for transthyretin (TTR) amyloidosis. The European market is expected to show significant growth during the forecast period due to main factors such as the availability of advanced treatment facilities, increased spending on healthcare, as well as an increasing need for better healthcare infrastructure, and government initiatives to reform health care. Approximately 60 new cases of transthyretin (TTR) amyloidosis are recorded annually in the United Kingdom, and the age-specific incidence rate is between 5.1 and 12.8 per million per year. In addition, the growing demand for medical devices and the capability of people to afford diagnostics contribute to the industry’s growth. However, the inefficiency of treatment and the incorrect diagnosis is hindering the growth of the market in this area.

The Asia Pacific is anticipated to be the fastest-growing region. According to a study published by the United Nations in 2015, the number of older adults aged 60 years or older in the world is expected to rise by 56% between 2015 and 2030, of which 66% of the elderly reside in the Asia Pacific region. It makes the region vulnerable to transthyretin (TTR) amyloidosis as the chances of its occurrence increase with rising age. Due to a broad patient population, rapid adoption of healthcare technologies, government initiatives to enhance healthcare quality, and availability of favorable reimbursement and insurance policies, market growth will accelerate throughout the forecast period. In addition, major players such as Pfizer, Merck, etc. have developed their regional headquarters and manufacturing facilities in countries like Singapore, China, Japan, Korea, and Australia. As a result, the growth curve of the in transthyretin (TTR) amyloidosis market will show a positive growth pattern.

The Middle East and Africa are anticipated to exhibit the lowest growth in the market due to some key factors such as dearth of awareness and limited access and availability of treatment facilities. In the Middle East, Saudi Arabia and the United Arab Emirates are the major markets due to the development of the healthcare sector and the increasing availability of specialized care centers. However, the market may show steady growth due to the genetic vulnerability of Africans to transthyretin amyloidosis and government initiatives to augment the quality of healthcare in the region.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/transthyretin-amyloidosis-market-6155

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cough Syrup Market, Segments, Growth And Value Chain Analysis 2020

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Cough Syrup Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Cough syrup is a medicine prescribed by doctors for patients with runny nose, sneezing, common cold, and other respiratory allergies. Availability of the medicine at over-the-counter (OTC) pharmacies and its efficacy in providing relief has widened its scope. The global cough syrup market report by Market Research Future (MRFR) contains valuable insights and measures for syrup producers for the period of 2019 to 2026 (forecast period). The outbreak of the COVID-19 virus and its impact on the industry has been explored as well.

Also Read : https://www.medgadget.com/2020/07/covid-19-impact-on-cough-syrup-market-growth-2020-industry-size-estimation-global-share-swot-analysis-application-top-companies-merger-regional-revenue.html

Cough Syrup Market Scope

The global cough syrup market is expected to register a CAGR of 3.45% to reach USD 5,139.63 million by 2026. Rise of respiratory disorders, common cold, and the surge in pollution levels can drive the market growth exponentially. According to the Forum of International Respiratory Societies (FIRS), indoor air pollution, pollution from traffic, and tobacco smoke are main causes of air pollution. This is evident with 4.3 million deaths have been caused by air pollution, as per the report by WHO. The large elderly populace and the active pharmaceutical sector are other drivers of the market.

The misuse of cough syrup by consumers can deter its market growth.

Cough Syrup Market Segmentation

The global cough syrup market has been segmented into product type, category, and application.

Based on product type, the market has been segregated into combination and individuals. Combination product type has been further classified as dextromethorphan + guaifenesin, guaifenesin + pseudoephedrine, and brompheniramine + pseudoephedrine. The individual product type has been further divided into dextromethorphan, guaifenesin, ambroxol, and codeine.

Based on the category, the market has been segmented into cough suppressants and expectorants.

By application, the cough syrup market has been categorized as adults and child.

Cough Syrup Market Regional Analysis

The global cough syrup market, based on region, has been divided into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas is expected to hold a maximum share of the global cough syrup market and is projected to register a CAGR of 3.16% during the forecast period. Presence of significant market players, strategic acquisitions by major players, increasing cases of respiratory disorders, and availability of advanced medications for the treatment of chronic obstructive pulmonary disease (COPD) are main drivers of the regional market. The low growth risk and high competition can ensure the steady growth of the market.

Europe accounts for the second-largest, in the global cough syrup market, majorly due to the presence of key players such as GlaxoSmithKline, Reckitt Benckiser Group PLC, and Novartis. Moreover, the purchase of over-the-counter (OTC) syrups from retail pharmacies over the preference of the local healthcare provider can bode well for the market.

APAC is estimated to be the fastest-growing market due to the continuous development in developing countries such as India and China. High prevalence of respiratory disorders due to vehicular pollution, tobacco smoke, exposure to air pollutants at home and the workplace, and indoor air pollution from biological agents are major drivers of the regional cough syrup market. The prevalence of smog due to industrial pollution in China can drive the product sales.

The MEA cough syrup market is driven by advances in healthcare infrastructure, increasing healthcare expenditure, and increasing per capita disposable incomes of the people in the UAE and Saudi Arabia. Africa is the least developed region with limited healthcare resources and facilities for the people. The low growth rate due to less developed and less efficient health systems is hampering the growth of the market.

Cough Syrup Market Competitive Outlook

Reckitt Benckiser Group PLC, Merck KGaA, Johnson & Johnson Services, Inc., Novartis AG, Sanofi, Procter & Gamble, Abbott, Acella Pharmaceuticals, LLC, Pfizer, Inc., and GlaxoSmithKline PLC are key players of the global cough syrup market.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/cough-syrup-market-8217

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Plasma Fractionation Market 2019 Share, Trend, Segmentation And Forecast To 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Plasma Fractionation Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Plasma Fractionation Market Analysis

The global plasma fractionation market is predicted to grow at a healthy 6.5% CAGR between 2018- 2023, as per the recent analysis by Market Research Future (MRFR). Plasma is a blood component that is derived by plasmapheresis from whole blood and used in different medical and therapeutic applications. It is a source of different proteins of which just a few are useful to produce therapeutic plasma products. The process to separate, extract, and purify these proteins from the plasma is known as the fractionation process. This process is based upon various criteria like temperature, product solubility, and their chemical & physical conditions like ionic strengths and pH levels. Protease inhibitors, albumin, coagulation factor concentrates, immunoglobulin, and others are the different types of plasma fractionation products.

Also Read : https://www.medgadget.com/2020/07/plasma-fractionation-market-to-grow-at-6-5-cagr-by-2023-covid-19-impact-analysis-global-share-industry-size-top-company-revenue.html

Various factors are propelling the global plasma fractionation market growth. As per the latest MRFR report, such factors include increasing use of immunoglobulin in different therapeutic areas, a rise in plasma collection, growing use of alpha-1-antitrypsin, and an increase in plasma collection centers. Additional factors adding market growth include the rising prevalence of autoimmune and respiratory disorders, technological advances, and rising geriatric population.

On the contrary, unfavorable reimbursement policies, the high price of advanced products, the effect of the COVID-19 outbreak, and the availability of recombinant alternatives are factors that may limit the global plasma fractionation market growth over the forecast period.

Plasma Fractionation Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global plasma fractionation market report based on end user, application, and product.

Based on product, the plasma fractionation market has been segmented into immunoglobulin, protease inhibitors, coagulation factor concentrates, albumin, and others. The immunoglobulin segment is again segmented into subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin (IVIG), and others. The coagulation factor is again segmented into factor XIII, fibrinogen concentrates, prothrombin complex concentrate, von willebrand factor, factor IX, and factor VIII. Of these, the immunoglobulin segment will lead the market over the forecast period.

Based on application, the plasma fractionation market has been segmented into hemato-oncology, pulmonology, rheumatology, critical care, neurology, hematology, immunology, and others. Among these, the neurology segment will dominate the market during the forecast period.

Based on end user, the plasma fractionation market has been segmented into clinical research laboratories, academic institutes, hospitals and clinics, & others. Among these, hospitals & clinics will have a major share in the market over the forecast period.

Plasma Fractionation Market Regional Analysis

Based on the region, the global plasma fractionation market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific, & the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. Rising cases of immunodeficiency disorders coupled with the presence of top market players are adding to the global plasma fractionation market growth in the region.

The global plasma fractionation market in Europe is predicted to have the second-largest share over the forecast period. Surging research and development investments & increasing technological advances are adding to the global plasma fractionation market growth in the region.

The global plasma fractionation market in the APAC region is predicted to grow at a fast pace over the forecast period. Rising healthcare expenditures is adding to the global plasma fractionation market growth in the region.

The global plasma fractionation market in the MEA is predicted to have the smallest share during the forecast period due to the inadequate economic development, especially in the African region.

Plasma Fractionation Market Key Players

Eminent players in the plasma fractionation market report include Shire, Shanghai RAAS, Octapharma AG, Japan Blood Products Organization,LFB Group, Kedrion S.p.A, Grifols, S.A., China Biologic Products Holdings, Green Cross Corporation, CSL Limited, Inc., Biotest AG, and Bio Products Laboratory (BPL).

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/plasma-fractionation-market-7397